NCT03217734 - MAP Study: Methotrexate and Adalimumab in Psoriasis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 10, 2017

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions

Psoriasis

Interventions

BIOLOGICAL

Adalimumab

Subcutaneous Injection

DRUG

Methotrexate

Oral Tablet

DRUG

Placebo

Oral Tablet

Trial Locations (4)

DermAssociates, PC, Rockville

Modern Research Associates, PLLC, Dallas

Clinical Science Institute, Santa Monica

Bakersfield Dermatology and Skin Cancer Medical Group, Bakersfield